Business Notes: Bethesda Toyota Dealer Nominated for Dealer of the Year
Plus: Rockville biotech company submits possible HIV/AIDS cure to FDA; Landscape store manager to be honored
Jim Coleman Toyota
Bethesda’s Jim Coleman Toyota has been nominated for Dealer of the Year from Time magazine and Ally Financial. The two organizations announced the award in a press release Oct. 22.
The Dealer of the Year Award is given to one of the country’s most successful dealers who also has a history of community service, according to the press release.
Coleman, 65, will be honored at the National Automobile Dealers Association Show in Las Vegas Feb. 15 with 48 other dealer representatives across the country.
Coleman was nominated by Peter Kitzmiller, the president of the Maryland Automobile Dealers Association.
From the 49 dealers, a panel of faculty members from the University of Michigan’s Tauber Institute for Global Operations will pick four finalists and one National Dealer of the Year, according to the press release. Three finalists will receive $5,000 for charity and the winner will receive $10,000.
Coleman grew up in Bethesda and after college, went to work for his father William’s Cadillac dealership in 1975. Coleman eventually bought his father’s dealership and expanded the business to include six car brands under the umbrella of Jim Coleman Automotive.
Rockville company submits possible HIV/AIDS cure to FDA
American Gene Techologies, a Rockville biotechnology company, announced last month that it has submitted an application to the Food and Drug Administration for approval of a drug that could cure HIV/AIDS.
The drug, called AGT 103-T, modifies human cells in a way that makes them impossible for the disease to infect, company CEO Jeff Galvin said in an interview Wednesday.
“There are people who are naturally immune to HIV. It’s a very rare condition. We give that condition to anybody,” he said.
Galvin said he has had the idea for a drug that could cure HIV/AIDS since he started his company 12 years ago, but started pursuing it more seriously around 2012. The timeline for approval, he said, is up to the FDA.
“We’ve fulfilled our original agreement with them to show them certain safety data. They have to look at that and say, does our data conform to what we agreed to,” he said.
Galvin said the FDA must determine whether the drug is safe for human trial.
Manager of D.C.-area landscape supply stores to be honored
Jeff Waters, the manager for SiteOne Landscape Supply’s Washington, D.C.-area stores, will be honored Dec. 5 in Gaithersburg. He will receive the Landscape Leadership Award at the Landscape Awards Celebration Dinner.
Waters started working as a sales manager at Shemin Nurseries in 1994 and became general manager when it expanded. In 2015, Shemin was acquired by John Deere Landscapes and rebranded as SiteOne Landscape Supply, according to a press release.
Waters has served on the Garden Centers of America’s board, as well as the Maryland Nurserymen’s Association board.
Dan Schere can be reached at Daniel.firstname.lastname@example.org